JP6304744B2 - 愛着障害治療剤 - Google Patents

愛着障害治療剤 Download PDF

Info

Publication number
JP6304744B2
JP6304744B2 JP2013264454A JP2013264454A JP6304744B2 JP 6304744 B2 JP6304744 B2 JP 6304744B2 JP 2013264454 A JP2013264454 A JP 2013264454A JP 2013264454 A JP2013264454 A JP 2013264454A JP 6304744 B2 JP6304744 B2 JP 6304744B2
Authority
JP
Japan
Prior art keywords
oxytocin
attachment
therapeutic agent
disorder
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013264454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015120650A5 (enExample
JP2015120650A (ja
Inventor
明美 友田
明美 友田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Fukui NUC
Original Assignee
University of Fukui NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Fukui NUC filed Critical University of Fukui NUC
Priority to JP2013264454A priority Critical patent/JP6304744B2/ja
Publication of JP2015120650A publication Critical patent/JP2015120650A/ja
Publication of JP2015120650A5 publication Critical patent/JP2015120650A5/ja
Application granted granted Critical
Publication of JP6304744B2 publication Critical patent/JP6304744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013264454A 2013-12-20 2013-12-20 愛着障害治療剤 Active JP6304744B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013264454A JP6304744B2 (ja) 2013-12-20 2013-12-20 愛着障害治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013264454A JP6304744B2 (ja) 2013-12-20 2013-12-20 愛着障害治療剤

Publications (3)

Publication Number Publication Date
JP2015120650A JP2015120650A (ja) 2015-07-02
JP2015120650A5 JP2015120650A5 (enExample) 2016-12-15
JP6304744B2 true JP6304744B2 (ja) 2018-04-04

Family

ID=53532654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013264454A Active JP6304744B2 (ja) 2013-12-20 2013-12-20 愛着障害治療剤

Country Status (1)

Country Link
JP (1) JP6304744B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI745313B (zh) * 2015-10-30 2021-11-11 日商帝人製藥股份有限公司 鼻黏膜投與用醫藥組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1556068B1 (en) * 2002-10-03 2010-08-18 Neuropharmacology Services, LLC Oxytocin for use in the treatment of Autism and Asperger's disorder

Also Published As

Publication number Publication date
JP2015120650A (ja) 2015-07-02

Similar Documents

Publication Publication Date Title
US12128075B2 (en) Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
JP5289765B2 (ja) 自閉症、強迫神経症、および衝動性の治療のためのメマンチン（ナメンダ）の使用
AU2021250982B2 (en) Neuroactive steroid solutions and their methods of use
US11844805B2 (en) Formulations of testosterone and methods of treatment therewith
US20220387447A1 (en) Formulations of testosterone and methods of treatment therewith
US20170333560A1 (en) Pharmaceutical Composition That Includes A Neutral Carrier Treated With Energy And Related Methods Of Treatment
Bassetti et al. Poststroke hypersomnia
EP4048249B1 (en) Methods of treating the symptoms of autism spectrum disorder
JP2015120650A (ja) 愛着障害治療剤
JP7312340B2 (ja) 水素を含む加齢黄斑変性治療用組成物
Thom et al. Psychiatric comorbidity in individuals with autism
CA3054679A1 (en) Method for preventing or treating autism spectrum disorders by benzoic acid salt
MX2011010077A (es) Composicion para regular la actividad nerviosa autonoma y metodo para regular el nervio autonomo.
WO2020259540A1 (zh) 唾液酸类化合物在制备治疗脑部退行性病变药物或营养添加剂或食品中的应用
AU2011235981B2 (en) Use of Memantine (Namenda) to Treat Autism, Compulsivity, and Impulsivity
RU2844953C1 (ru) Способы лечения симптомов расстройства аутистического спектра
DE102007004991B4 (de) Verwendung von RiV-Präparaten zur Behandlung des Hirninfarktes
Meighen et al. Ziprasidone treatment of two adolescents with psychosis
RU2803464C2 (ru) Нейроактивные стероидные растворы и способы их применения
WO2023215338A1 (en) Compositions and methods for treating cluster headache
JPH0813751B2 (ja) 人尿性キニノゲナーゼを有効成分とする脳機能改善剤
WO2023215344A2 (en) Compositions and methods for treating cluster-tic syndrome
HK40080588A (en) Methods of treating the symptoms of autism spectrum disorder
Webster et al. Long-term hyperbaric oxygen therapy for multiple sclerosis patients
Karakuła et al. Familial occurrence of bipolar disorder–case reports

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161026

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161026

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170721

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180119

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180301

R150 Certificate of patent or registration of utility model

Ref document number: 6304744

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250